BioSig Technologies Announces FDA 510(k) Clearance for PURE EP System
14 août 2018 08h07 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Aug. 14, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), announced that the Company has received 510(k) clearance for its first product, PURE EP System, from...
BioSig Technologies Completes Private Placement
13 août 2018 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Added to LD Micro Index
06 août 2018 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Aug. 06, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an...
BioSig Technologies Files Application to Uplist to the NASDAQ
01 août 2018 09h32 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Aug. 01, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an...
BioSig Technologies Ranked Top 50 for The Silicon Review’s Innovative Companies to Watch in 2018
24 juil. 2018 09h30 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, July 24, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies to Present at the 40th International Conference of the IEEE Engineering in Medicine and Biology Society
11 juil. 2018 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, July 11, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies to Present at the Emerging Medical Technologies Spotlight
29 juin 2018 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, June 29, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to...
BIOLIFE4D Successfully Demonstrates Ability to 3D Bioprint Human Cardiac Tissue
25 juin 2018 08h00 HE
|
BIOLIFE4D Corporation
CHICAGO, June 25, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully...
BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Due to Popular Demand
23 juin 2018 08h00 HE
|
BIOLIFE4D Corporation
CHICAGO, June 23, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it will be modifying...
Aphios and LSU Health Shreveport Inventors Granted Patent to Improve Transplantation
19 juin 2018 08h00 HE
|
Aphios
WOBURN, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it and the LSU Health Shreveport Department of Molecular & Cellular Physiology have been granted United...